Rayo 3D Biotech Oy – Trademark Portfolio

Entity Type: 99

Rayo 3D Biotech Oy holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include INLIQ-3D and RAYO 3D TOOTHFILL.

Kassivikintie 99-34

FI-01180 KALKKIRANTA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Rayo 3D Biotech Oy's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does Rayo 3D Biotech Oy have?

Rayo 3D Biotech Oy has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Rayo 3D Biotech Oy file in?

Rayo 3D Biotech Oy files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Rayo 3D Biotech Oy's most well-known trademarks?

Rayo 3D Biotech Oy's registered trademark portfolio includes well-known marks such as INLIQ-3D and RAYO 3D TOOTHFILL. These are among 2 currently registered trademarks in the portfolio.

What is Rayo 3D Biotech Oy's trademark registration success rate?

Rayo 3D Biotech Oy has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.